RIPK1-IN-4 is primarily used in biomedical research to study the role of RIPK1 (Receptor-Interacting Serine/Threonine-Protein Kinase 1) in cellular processes. It is a selective inhibitor of RIPK1, which plays a critical role in regulating cell death pathways, including apoptosis and necroptosis. By inhibiting RIPK1, researchers can investigate its involvement in inflammatory diseases, neurodegenerative disorders, and cancer. This compound is particularly valuable in preclinical studies aimed at understanding the mechanisms of cell survival and death, as well as in developing potential therapeutic strategies for conditions where RIPK1 activity is dysregulated. Its application extends to exploring the therapeutic potential of targeting RIPK1 in diseases such as Alzheimer's, multiple sclerosis, and inflammatory bowel disease.